Dextromethorphan phenotypes in paediatric patients with autoimmune hepatitis.

Por Jacqz-Aigrain, E, Laurent, J, Alvarez, F
Publicado em 1990

Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese.

Por Mura, C, Broyard, J P, Jacqz-Aigrain, E, Krishnamoorthy, R
Publicado em 1991

Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors.

Por Jacqz-Aigrain, E, Bessa, E, Medard, Y, Mircheva, Y, Vilmer, E
Publicado em 1994

Continuous infusion of zidovudine in HIV related thrombocytopenia.

Por Rahimy, C, Jacqz-Aigrain, E, Broyard, A, Brun-Vézinet, F, Vilmer, E
Publicado em 1993

Endogenous digoxin-like immunoreactivity during pregnancy and at birth.

Por Lupoglazoff, J M, Jacqz-Aigrain, E, Guyot, B, Chappey, O, Blot, P
Publicado em 1993

CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2and CYP2D6*17alleles to the high prevalence of the intermediate metabolic phenotype

Por Panserat, S, Sica, L, Gérard, N, Mathieu, H, Jacqz-Aigrain, E, Krishnamoorthy, R
Publicado em 1999

Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients

Por PAREZ, N, HERZOG, D, JACQZ-AIGRAIN, E, HOMBERG, J-C, ALVAREZ, F
Publicado em 1996

Population Pharmacokinetics of Ciprofloxacin in Pediatric and Adolescent Patients with Acute Infections

Por Payen, S., Serreau, R., Munck, A., Aujard, Y., Aigrain, Y., Bressolle, F., Jacqz-Aigrain, E.
Publicado em 2003

Molecular heterogeneity of the XbaI defined 44kb allele of the CYP2D locus within the Caucasian population.

Por Mura, C, Gerard, N, Vincent-Viry, M, Galteau, M M, Jacqz-Aigrain, E, Krishnamoorthy, R
Publicado em 1993

Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine

Por Dervieux, T, Médard, Y, Baudouin, V, Maisin, A, Zhang, D, Broly, F, Loirat, C, Jacqz-Aigrain, E
Publicado em 1999

N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients.

Por Deloménie, C, Grant, D M, Mathelier-Fusade, P, Jacomet, C, Leynadier, F, Jacqz-Aigrain, E, Rozenbaum, W, Krishnamoorthy, R, Dupret, J M
Publicado em 1994

Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open‐label clinical trial

Por Leroux, S., Jacqz‐Aigrain, E., Elie, V., Legrand, F., Barin‐Le Guellec, C., Aurich, B., Biran, V., Dusang, B., Goudjil, S., Coopman, S., Garcia Sanchez, R., Zhao, W., Manzoni, P.
Publicado no Br J Clin Pharmacol (2018)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children

Por Li Q, Wang K, Shi HY, Wu YE, Zhou Y, Kan M, Zheng Y, Hao GX, Yang XM, Yang YL, Su LQ, Wang XL, Jacqz-Aigrain E, Zhou J, Zhao W
Publicado em 2019-12-01

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates

Por Ramos-Martín, V., Johnson, A., Livermore, J., McEntee, L., Goodwin, J., Whalley, S., Docobo-Pérez, F., Felton, T. W., Zhao, W., Jacqz-Aigrain, E., Sharland, M., Turner, M. A., Hope, W. W.
Publicado no J Antimicrob Chemother (2016)

Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Por Ruggieri, L., Giannuzzi, V., Baiardi, P., Bonifazi, F., Davies, E. H., Giaquinto, C., Bonifazi, D., Felisi, M., Chiron, C., Pressler, R., Rabe, H., Whitaker, M. J., Neubert, A., Jacqz-Aigrain, E., Eichler, I., Turner, M. A., Ceci, A.
Publicado no Eur J Pediatr (2014)